Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zai Lab (ZLAB) Liabilities and Shareholders Equity: 2018-2024

Historic Liabilities and Shareholders Equity for Zai Lab (ZLAB) over the last 7 years, with Dec 2024 value amounting to $1.2 billion.

  • Zai Lab's Liabilities and Shareholders Equity rose 17.62% to $1.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $4.7 billion, marking a year-over-year increase of 17.13%. This contributed to the annual value of $1.2 billion for FY2024, which is 14.42% up from last year.
  • According to the latest figures from FY2024, Zai Lab's Liabilities and Shareholders Equity is $1.2 billion, which was up 14.42% from $1.0 billion recorded in FY2023.
  • Zai Lab's Liabilities and Shareholders Equity's 5-year high stood at $1.6 billion during FY2021, with a 5-year trough of $1.0 billion in FY2023.
  • Moreover, its 3-year median value for Liabilities and Shareholders Equity was $1.2 billion (2024), whereas its average is $1.1 billion.
  • Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first surged by 265.37% in 2020, then declined by 24.21% in 2022.
  • Zai Lab's Liabilities and Shareholders Equity (Yearly) stood at $1.3 billion in 2020, then grew by 24.07% to $1.6 billion in 2021, then dropped by 24.21% to $1.2 billion in 2022, then declined by 15.07% to $1.0 billion in 2023, then rose by 14.42% to $1.2 billion in 2024.